Literature DB >> 26212823

Gastro-oesophageal reflux disease: illness or illusion?

A Pali S Hungin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26212823      PMCID： PMC4513715          DOI： 10.3399/bjgp15X685993

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  9 in total

1.  Oesophageal mucosal barrier: a key factor in the pathophysiology of non-erosive reflux disease (NERD) and a potential target for treatment.

Authors:  Philip Woodland; Daniel Sifrim
Journal:  Gut       Date:  2013-07-06       Impact factor: 23.059

2.  The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD.

Authors:  Hanneke Beaumont; Roelof J Bennink; Jan de Jong; Guy E Boeckxstaens
Journal:  Gut       Date:  2009-08-02       Impact factor: 23.059

3.  Treatment of GORD: Three decades of progress and disappointments.

Authors:  Jean Paul Galmiche; Frank Zerbib; Stanislas Bruley des Varannes
Journal:  United European Gastroenterol J       Date:  2013-06       Impact factor: 4.623

4.  Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study.

Authors:  Eivind Ness-Jensen; Anna Lindam; Jesper Lagergren; Kristian Hveem
Journal:  Gut       Date:  2011-12-21       Impact factor: 23.059

5.  An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.

Authors:  M A Kwiatek; S Roman; A Fareeduddin; J E Pandolfino; P J Kahrilas
Journal:  Aliment Pharmacol Ther       Date:  2011-05-03       Impact factor: 8.171

6.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

7.  Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.

Authors:  John Dent; Nimish Vakil; Roger Jones; Peter Bytzer; Uwe Schöning; Katarina Halling; Ola Junghard; Tore Lind
Journal:  Gut       Date:  2010-06       Impact factor: 23.059

8.  Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.

Authors:  A S Raghunath; A P S Hungin; J Mason; W Jackson
Journal:  Aliment Pharmacol Ther       Date:  2008-11-17       Impact factor: 8.171

9.  Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.

Authors:  I Mainie; R Tutuian; S Shay; M Vela; X Zhang; D Sifrim; D O Castell
Journal:  Gut       Date:  2006-03-23       Impact factor: 23.059
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.